Perspective · 10 Sep 2024
Conference abstractPublished 2 Nov 2017
Novel particulate vaccines for infectious diseases
Mercer University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We have been working on designing and developing nanovaccines for infectious diseases at the Nanotechnology Laboratory at Mercer University. In particular, we focus on particulate vaccines that offer several advantages over the traditional vaccines, such as superior vaccine stability, the avoidance of cold-chain requirements, and the ease of manufacture. Further, the overall enhanced immune response due to a combination of factors, such as slow release of antigen from the particles and superior uptake into antigen presenting cells of the immune system, makes particulate vaccines the preferred choice of vaccine delivery. The availability of safe bio-degradable and bio-compatible polymers enhances its suitability for human use. Novel delivery of microparticulate vaccines such as transdermal delivery using microneedles and laser ablation, nasal delivery, buccal delivery, and oral delivery of vaccines, amongst others, will also be discussed. Several examples of successful delivery of particulate vaccines in the areas of infectious diseases such as gonorrhea, RSV, influenza, will be discussed.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Mini review · 30 Nov 2022
A Short Note on the Enhanced infectious diseases vaccines
Conference abstract · 20 Feb 2017
Vaccines for key unmet Medical (Infectious Disease) needs in the developing world: Learning and reflections from the India Polio eradication success story
Conference abstract · 20 Feb 2017
The use of new adjuvants and VLPs for the development of vaccines for emerging and infectious diseases
Conference abstract · 20 Oct 2016
Photodynamically inactivated Leishmania for safe and effective delivery of vaccines for immunotherapy of infectious and malignant diseases
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectInfectious Diseases
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Martin J D’Souza”
